AAAAAA

   
Results: 1-9 |
Results: 9
2-YEAR REVIEW OF HEPATITIS-A VACCINE SAFETY - DATA FROM THE VACCINE-ADVERSE-EVENT-REPORTING-SYSTEM (VAERS)
Authors: NIU MT SALIVE M KRUEGER C ELLENBERG SS
Citation: Mt. Niu et al., 2-YEAR REVIEW OF HEPATITIS-A VACCINE SAFETY - DATA FROM THE VACCINE-ADVERSE-EVENT-REPORTING-SYSTEM (VAERS), Clinical infectious diseases, 26(6), 1998, pp. 1475-1476
COMPARATIVE SAFETY OF 2 RECOMBINANT HEPATITIS-B VACCINES IN CHILDREN - DATA FROM THE VACCINE ADVERSE EVENT REPORTING SYSTEM (VAERS) AND VACCINE SAFETY DATALINK (VSD)
Authors: NIU MT RHODES P SALIVE M LIVELY T DAVIS DM BLACK S SHINEFIELD H CHEN RT ELLENBERG SS
Citation: Mt. Niu et al., COMPARATIVE SAFETY OF 2 RECOMBINANT HEPATITIS-B VACCINES IN CHILDREN - DATA FROM THE VACCINE ADVERSE EVENT REPORTING SYSTEM (VAERS) AND VACCINE SAFETY DATALINK (VSD), Journal of clinical epidemiology, 51(6), 1998, pp. 503-510
HAIR LOSS AFTER IMMUNIZATION - REPLY
Authors: WISE RP SALIVE ME NIU MT
Citation: Rp. Wise et al., HAIR LOSS AFTER IMMUNIZATION - REPLY, JAMA, the journal of the American Medical Association, 279(2), 1998, pp. 118-118
ZIDOVUDINE TREATMENT IN PATIENTS WITH PRIMARY (ACUTE) HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
Authors: NIU MT BETHEL J HOLODNIY M STANDIFORD HC SCHNITTMAN SM
Citation: Mt. Niu et al., ZIDOVUDINE TREATMENT IN PATIENTS WITH PRIMARY (ACUTE) HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL, The Journal of infectious diseases, 178(1), 1998, pp. 80-91
RECOMBINANT HEPATITIS-B VACCINATION OF NEONATES AND INFANTS - EMERGING SAFETY DATA FROM THE VACCINE ADVERSE EVENT REPORTING SYSTEM
Authors: NIU MT DAVIS DM ELLENBERG S
Citation: Mt. Niu et al., RECOMBINANT HEPATITIS-B VACCINATION OF NEONATES AND INFANTS - EMERGING SAFETY DATA FROM THE VACCINE ADVERSE EVENT REPORTING SYSTEM, The Pediatric infectious disease journal, 15(9), 1996, pp. 771-776
SUMMARY OF THE NATIONAL-INSTITUTES-OF-HEALTH WORKSHOP ON PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION
Authors: NIU MT JERMANO JA REICHELDERFER P SCHNITTMAN SM
Citation: Mt. Niu et al., SUMMARY OF THE NATIONAL-INSTITUTES-OF-HEALTH WORKSHOP ON PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION, AIDS research and human retroviruses, 9(9), 1993, pp. 913-924
MULTICENTER STUDY OF HEPATITIS-C VIRUS-INFECTION IN CHRONIC-HEMODIALYSIS PATIENTS AND HEMODIALYSIS CENTER STAFF MEMBERS
Authors: NIU MT COLEMAN PJ ALTER MJ
Citation: Mt. Niu et al., MULTICENTER STUDY OF HEPATITIS-C VIRUS-INFECTION IN CHRONIC-HEMODIALYSIS PATIENTS AND HEMODIALYSIS CENTER STAFF MEMBERS, American journal of kidney diseases, 22(4), 1993, pp. 568-573
PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION - REVIEW OF PATHOGENESIS AND EARLY TREATMENT INTERVENTION IN HUMANS AND ANIMAL RETROVIRUS INFECTIONS
Authors: NIU MT STEIN DS SCHNITTMAN SM
Citation: Mt. Niu et al., PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION - REVIEW OF PATHOGENESIS AND EARLY TREATMENT INTERVENTION IN HUMANS AND ANIMAL RETROVIRUS INFECTIONS, The Journal of infectious diseases, 168(6), 1993, pp. 1490-1501
TREATMENT TRIALS FOR PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION
Authors: NIU MT STEIN DS SCHNITTMAN SM
Citation: Mt. Niu et al., TREATMENT TRIALS FOR PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION, The Journal of infectious diseases, 168(6), 1993, pp. 1601-1602
Risultati: 1-9 |